Elevated levels of ADAM10 have been associated with poor prognosis in cancers such as glioblastoma and breast cancer [74,75,76], and ADAM10 shows potential as a pan-cancer biomarker [77]. The gene discussed is ADAM10; the disease is breast cancer.